Skip to content

Return on equity at other companies

Humana logo
HumanaHUM
18.2%+0.9pp
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
11.8%-11.1pp
Alignment Healthcare logo
Alignment HealthcareALHC
12.6%+6.8pp
Astrana Health logo
Astrana HealthASTH
3.9%
Elevance Health logo
Elevance HealthELV
12.1%-2.1pp

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Calculated from Clover Health Investments’s reported figures.

Based on trailing twelve months.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's return on equity?
Clover Health Investments (CLOV) reported return on equity of -16.9% in Q1 2026.
How has Clover Health Investments's return on equity changed year-over-year?
Clover Health Investments's return on equity decreased by 111.0% year-over-year, from -8% to -16.9%.
What is the long-term trend for Clover Health Investments's return on equity?
Over 3 years (2022 to 2025), Clover Health Investments's return on equity has grown at a -29.8% compound annual growth rate (CAGR), from -76.1% to -26.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.